Preimplantation Genetic Testing Market: Genetic Screening is Estimated to Create More than US$ 100 million Incremental Opportunity throughout the Forecast period 2017-2022

The global market discussion on preimplantation genetic testing industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Preimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on preimplantation genetic testing market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=292

According to a new study by Fact.MR, the global preimplantation genetic testing market is likely to witness robust growth and it is estimated to increase to 8.4% CAGR during the forecast period, 2017-2022. Owing to the increased risk of various diseases, the preimplantation genetic testing which includes profiling of embryos even before implantation is gaining popularity. Moreover, the absence of cures for various genetic conditions is driving the demand for preimplantation genetic testing. The preimplantation genetic testing is witnessing a rise in demand due to the high chances of pregnancy with this procedure as compared to the other treatments.

6 Forecast Highlights on Global Preimplantation Genetic Testing Market

1- North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.

2- Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.

3- A genetic screening test is likely to emerge as one of the most preferred test types in the global preimplantation genetic testing market. By the end of 2022, Genetic screening is projected to surpass US$ 300 million revenue.

4- Specialized clinics are likely to be the largest users of the preimplantation genetic testing. By the end of 2017, specialized clinics are projected to account for nearly two-fifth of the revenue share on the global revenue.

Genetic Screening to Emerge as the Highly Preferred Test Type

Genetic screening is expected to be the highly preferred test type as compared to genetic diagnosis. Gaining nearly two-third of the share in terms of revenue towards 2017 end, genetic screening is estimated to create more than US$ 100 million incremental opportunity throughout the forecast period.

Specialized Clinics to Account for Maximum Share

Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth throughout the forecast period.

Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy

Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.

Browse Full Report with TOC@ https://www.factmr.com/report/292/preimplantation-genetic-testing-market

Table of Contents:

Global Preimplantation Genetic Testing Market – Executive Summary
Global Preimplantation Genetic Testing Market Overview
2.1. Introduction
2.1.1. Global Preimplantation Genetic Testing Market Taxonomy
2.1.2. Global Preimplantation Genetic Testing Market Definition
2.2. Global Preimplantation Genetic Testing Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Preimplantation Genetic Testing Market Y-o-Y Growth
2.3. Global Preimplantation Genetic Testing Market Dynamics
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis
2.7. Raw Material Sourcing Strategy and Analysis
2.8. Service Provider List
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Preimplantation Genetic Testing Market Analysis and Forecast By Test Type
3.1. Global Preimplantation Genetic Testing Market Size and Forecast By Test Type, 2012-2022
3.1.1. Genetic Diagnosis Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Genetic Screening Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
Continued…..

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=292

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.